Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase β is accentuated by BRCA2 mutation (Cancer Research (2010) 70, (409-17) DOI: 10.1158/0008-5472.CAN-09-1353)

G. C. Stachelek, S. Dalal, K. A. Donigan, D. C. Hegan, J. B. Sweasy, P. M. Glazer

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)1747
Number of pages1
JournalCancer Research
Issue number4
StatePublished - Feb 15 2010
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this